Assignee
IDUN PHARMACEUTICALS INC
US·34 granted patents·9 pending applications·526 citations·filing 1996–2005
Top patents by PatentIndex Score
43 records- 0189US6762045B2Membrane derived caspase-3, compositions comprising the same and methods of use thereforIDUN PHARMACEUTICALS INC·Filed 2002·Granted Jul 13, 2004·33 cites·21 claims
- 0289US6200969B1Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 1997·Granted Mar 13, 2001·38 cites·23 claims
- 0383US6197750B1C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1998·Granted Mar 6, 2001·60 cites·20 claims
- 0483US6184244B1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·46 cites·15 claims
- 0582US7183260B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2004·Granted Feb 27, 2007·17 cites·54 claims
- 0681US6693096B2Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Feb 17, 2004·11 cites·18 claims
- 0780US6544951B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Apr 8, 2003·14 cites·104 claims
- 0879US5869519AC-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Feb 9, 1999·56 cites·59 claims
- 0978US6270980B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1997·Granted Aug 7, 2001·36 cites·15 claims
- 1076US6187771B1Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 13, 2001·31 cites·27 claims
- 1175US5786173AMCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1996·Granted Jul 28, 1998·26 cites·31 claims
- 1273US6790989B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Sep 14, 2004·8 cites·25 claims
- 1373US6525024B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Feb 25, 2003·6 cites·43 claims
- 1472US7053056B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted May 30, 2006·6 cites·130 claims
- 1572US6610683B2Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Aug 26, 2003·4 cites·9 claims
- 1672US6528506B2Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Mar 4, 2003·4 cites·7 claims
- 1771US6251614B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Jun 26, 2001·25 cites·6 claims
- 1870US6531467B2Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·5 cites·77 claims
- 1969US6515173B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·5 cites·24 claims
- 2066US5968927ATricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 1997·Granted Oct 19, 1999·19 cites·48 claims
- 2164US6730779B2Antibody that specifically binds an Mch4 polypeptideIDUN PHARMACEUTICALS INC·Filed 2001·Granted May 4, 2004·1 cites·3 claims
- 2264US6489353B2C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Dec 3, 2002·1 cites·41 claims
- 2363US6444663B2Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Sep 3, 2002·1 cites·1 claims
- 2463US5990137AMethod of inhibiting NADPH oxidaseIDUN PHARMACEUTICALS INC·Filed 1998·Granted Nov 23, 1999·21 cites·33 claims
- 2562US6716960B2Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 2003·Granted Apr 6, 2004·0 cites·3 claims
- 2660US2003060416A1Blk genes, gene products and uses thereof in apoptosisIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2758US5939460AMethod of inhibiting NADPH oxidaseIDUN PHARMACEUTICALS INC·Filed 1996·Granted Aug 17, 1999·16 cites·3 claims
- 2857US7157430B2(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Jan 2, 2007·1 cites·2 claims
- 2956US6824991B2Human bad polypeptides, encoding nucleic acids and methods of useIDUN PHARMACEUTICALS INC·Filed 2001·Granted Nov 30, 2004·0 cites·8 claims
- 3056US5851815AMCH4 and MCH5, apoptotic proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Dec 22, 1998·17 cites·8 claims
- 3155US6969703B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Granted Nov 29, 2005·1 cites·42 claims
- 3253US2004058850A1Treatment of kidney disease or renal failure using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3352US2005065093A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3451US6391575B1Methods for detecting membrane derived caspase activity and modulators thereofIDUN PHARMACEUTICALS INC·Filed 1999·Granted May 21, 2002·12 cites·13 claims
- 3551US2006084613A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3651US2003119748A1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3750US2003092072A1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3850US2002197702A1Membrane derived caspase-3, compositions comprising the same and methods of use thereforIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3946US2002090666A1Methods for detecting membrane derived caspase activity and modulators thereofIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4043US2003232788A1(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4140US6518032B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 11, 2003·5 cites·32 claims
- 4234US6686459B1Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1998·Granted Feb 3, 2004·0 cites·7 claims
- 4329US6504022B1Human bad polypeptides, encoding nucleic acids and methods of useIDUN PHARMACEUTICALS INC·Filed 1999·Granted Jan 7, 2003·0 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →